BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28589873)

  • 41. Hcmv-miR-UL112 attenuates NK cell activity by inhibition type I interferon secretion.
    Huang Y; Chen D; He J; Cai J; Shen K; Liu X; Yang X; Xu L
    Immunol Lett; 2015 Feb; 163(2):151-6. PubMed ID: 25530545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNAs expressed by human cytomegalovirus.
    Zhang L; Yu J; Liu Z
    Virol J; 2020 Mar; 17(1):34. PubMed ID: 32164742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human cytomegalovirus-encoded microRNAs expression profile in plasma of patients with aortic dissection.
    Cheng Y; Du Y; Wang Q; Lv Q; Xue Y; Zhou W; Zhang C; Chen X; Wang D
    J Cardiothorac Surg; 2023 Jan; 18(1):39. PubMed ID: 36653806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rhesus cytomegalovirus encodes seventeen microRNAs that are differentially expressed in vitro and in vivo.
    Hancock MH; Tirabassi RS; Nelson JA
    Virology; 2012 Apr; 425(2):133-42. PubMed ID: 22305624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human Cytomegalovirus miR-UL70-3p Downregulates the H
    Pandeya A; Khalko RK; Mishra A; Singh N; Singh S; Saha S; Yadav S; Saxena S; Gosipatala SB
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008453
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The expression of interleukin-32 is activated by human cytomegalovirus infection and down regulated by hcmv-miR-UL112-1.
    Huang Y; Qi Y; Ma Y; He R; Ji Y; Sun Z; Ruan Q
    Virol J; 2013 Feb; 10():51. PubMed ID: 23402302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome.
    Varnum SM; Streblow DN; Monroe ME; Smith P; Auberry KJ; Pasa-Tolic L; Wang D; Camp DG; Rodland K; Wiley S; Britt W; Shenk T; Smith RD; Nelson JA
    J Virol; 2004 Oct; 78(20):10960-6. PubMed ID: 15452216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human MicroRNA Responses Predict Cytomegalovirus Replication Following Solid Organ Transplantation.
    Han SH; Kumar D; Ferreira VH; Egli A; Hirsch HH; Weisser M; Garzoni C; van Delden C; Bochud PY; Manuel O; Meylan P; Boggian K; Husain S; Mueller NJ; Humar A;
    J Infect Dis; 2017 Feb; 215(4):537-546. PubMed ID: 28003351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human cytomegalovirus (HCMV)-encoded microRNAs: potential biomarkers and clinical applications.
    Fernández-Moreno R; Torre-Cisneros J; Cantisán S
    RNA Biol; 2021 Dec; 18(12):2194-2202. PubMed ID: 34039247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytomegalovirus miRNAs target secretory pathway genes to facilitate formation of the virion assembly compartment and reduce cytokine secretion.
    Hook LM; Grey F; Grabski R; Tirabassi R; Doyle T; Hancock M; Landais I; Jeng S; McWeeney S; Britt W; Nelson JA
    Cell Host Microbe; 2014 Mar; 15(3):363-73. PubMed ID: 24629342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complexity of Host Micro-RNA Response to Cytomegalovirus Reactivation After Organ Transplantation.
    Egli A; Lisboa LF; O'Shea D; Asberg A; Mueller T; Emery V; Kumar D; Humar A
    Am J Transplant; 2016 Feb; 16(2):650-60. PubMed ID: 26460801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of RNA in purified cytomegalovirus virions.
    Sarcinella E; Brown M; Tellier R; Petric M; Mazzulli T
    Virus Res; 2004 Sep; 104(2):129-37. PubMed ID: 15246650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus.
    Irmiere A; Gibson W
    Virology; 1983 Oct; 130(1):118-33. PubMed ID: 6314643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytomegalovirus microRNAs.
    Hook L; Hancock M; Landais I; Grabski R; Britt W; Nelson JA
    Curr Opin Virol; 2014 Aug; 7():40-6. PubMed ID: 24769092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Profiling of microRNAs modulating cytomegalovirus infection in astrocytoma patients.
    Deshpande RP; Panigrahi M; Y B V K C; Babu PP
    Neurol Sci; 2018 Nov; 39(11):1895-1902. PubMed ID: 30090984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potent Inhibition of Human Cytomegalovirus by Modulation of Cellular SNARE Syntaxin 5.
    Cruz L; Streck NT; Ferguson K; Desai T; Desai DH; Amin SG; Buchkovich NJ
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential expression of basal microRNAs' patterns in human dental pulp stem cells.
    Vasanthan P; Govindasamy V; Gnanasegaran N; Kunasekaran W; Musa S; Abu Kasim NH
    J Cell Mol Med; 2015 Mar; 19(3):566-80. PubMed ID: 25475098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Viral miRNAs Alter Host Cell miRNA Profiles and Modulate Innate Immune Responses.
    Naqvi AR; Shango J; Seal A; Shukla D; Nares S
    Front Immunol; 2018; 9():433. PubMed ID: 29559974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hsa-miR-27b is up-regulated in cytomegalovirus-infected human glioma cells, targets engrailed-2 and inhibits its expression.
    Wang L; Yang M; Liao S; Liu W; Dai G; Wu G; Chen L
    Exp Biol Med (Maywood); 2017 Jun; 242(12):1227-1233. PubMed ID: 28343438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.